FDA Moves To Crack Down On Unapproved Oxycodone
The FDA said it knows that unapproved, single-ingredient, immediate-release oxycodone, both in tablets and oral solution, is currently being made and sold in the U.S. and could be a danger to patients.
Oxycodone is an extremely popular painkiller. Americans spent $2.9 billion on the approved extended-release drug Oxycontin, made by Purdue Pharma, in...
To view the full article, register now.